BioNexus Gene Lab (BGLC): Q3 Revenue Fell 98.12% as Trading at Chemrex Nearly Stopped
BioNexus Gene Lab reported a 98.12% drop in Q3 revenue for its Chemrex unit, resulting in a $1.88 million net loss. Auditors have expressed substantial doubt about the company's ability to continue as